Dear Dr. Jones, Our pharmaceutical company now received 47 complaints about the new pain reliever NoPain ,
Question:
Dear Dr. Jones,
Our pharmaceutical company now received 47 complaints about the new pain reliever NoPain, created in your lab. Of the 47 complaints, 24 said their headache got worse, 15 said they had severe cramping after taking the medication, and 8 said they had both problems. We have only been distributing this pain reliever for about 30 days and we are very concerned. It has cost our company roughly 1.2 million dollars to create the drug and we have recorded sales of $98,600 in the past month at $10 a bottle, so that is 9,860 bottles. Should we be concerned? Do you think we should pull the product and conduct more research? We may end up losing money on this if we pursue this course of action. Should we keep the product on the shelves and secretly do more research? Or should we just do nothing for the time being, wait it out, and see what happens? Please get back to us as soon as possible with your recommendation.
Dear Ms. Smith,
It would take the company 336 more days to earn back it's investment. I've included my calculations below for your review.
R = 98,600/30 $/day
R = 9860/3
Debt = 1,200,000 - 98,600
D = 1,101,400
Debt = r * days
1,101,400 = 9860/3 * days
335.1 = days
Evaluate the information given in the email. Using a free online tool, make a simple presentation that includes the following points:
- a pie chart displaying the different types of customer problems/complaints stated in the email
- findings regarding similar problems in the market
- a list of suggestions/alternatives that the company can use in order to solve the problem.
Income Tax Fundamentals 2013
ISBN: 9781285586618
31st Edition
Authors: Gerald E. Whittenburg, Martha Altus Buller, Steven L Gill